Please ensure Javascript is enabled for purposes of website accessibility
Home > Virus Guide > Alphavirus > Chikungunya virus (CHIKV)

Research-grade reagents for Chikungunya virus (CHIKV) — a mosquito-borne alphavirus causing debilitating polyarthralgia. E1/E2 envelope glycoproteins are key neutralization and vaccine targets. We offer recombinant/polyclonal/InVivoMAb antibodies, recombinant proteins, validated for ELISA, WB, IHC, FCM, IF, Neutralization. RUO

Why Researchers Choose abinScience

Recombinant Antibodies (23)Epitope-mapped clones for ELISA, WB, and immunoassay development. Suitable for diagnostic R&D and as reference standards.
Polyclonal Antibodies (6)Broad epitope recognition for Western blot and IHC detection. Validated for ELISA, WB, IHC, FCM, IF, Neutralization.
InVivoMAb Functional-Grade (1)Low-endotoxin, azide-free antibodies for in vivo neutralization, passive immunization, and functional blocking studies.
Recombinant Proteins (11)His-tagged and Fc-tagged antigens validated for SDS-PAGE, WB, and ELISA. Suitable as immunogens, coating antigens, and assay standards.

All products manufactured by AtaGenix Laboratories under ISO 9001 & ISO 13485 quality systems.

43 product results for "Chikungunya virus (CHIKV)"

Options+
Options
Confirm